We recently compiled a list of the Top 8 AI News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

Quest Diagnostics (NYSE:DGX) said on Wednesday that it expects first quarter revenue and EPS to take a hit from the weather ...

Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...

This week, Quest Diagnostics made one of those deals. The diagnostics giant announced a new partnership with Google Cloud that aims to deliver new AI capabilities — including predictive ...

Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.

Analysts have set 12-month price targets for Quest Diagnostics, revealing an average target of $179.44, a high estimate of ...

In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Quest Diagnostics (DGX – Research Report), ...

GE Healthcare, Synchron and robotics companies were among the medtech firms that used Nvidia’s GTC 2025 conference to share ...

Baird raised the firm’s price target on Quest Diagnostics (DGX) to $191 from $190 and keeps an Outperform rating on the shares. The firm ...

This was the stock's second consecutive day of losses.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...